Postoperative Acute Kidney Injury and Blood Product Transfusion After Synthetic Colloid Use During Cardiac Surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 31, Issue 3, 2017, Pages 853-862

  Tobey, Rajika ^a   Cheng, Hao ^a,b   Gao, Mei ^a,c   Li, Zhongmin ^a   Young, J Nilas ^a   Boyd, W Douglas ^a   Ji, Fuhai ^b   Liu, Hong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

acute kidney injury; blood products; cardiopulmonary bypass; hydroxyethyl starch; synthetic colloid

Indexed keywords

FRESH FROZEN PLASMA; HETASTARCH; HETASTARCH DERIVATIVE; PLASMA SUBSTITUTE;

ACUTE KIDNEY FAILURE; ADULT; AORTIC CLAMPING; ARTICLE; BLOOD TRANSFUSION; CLINICAL ASSESSMENT; COLLOID; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; FEMALE; HEART DISEASE; HEART SURGERY; HEART VALVE SURGERY; HUMAN; INTRAAORTIC BALLOON PUMP; INTRAOPERATIVE PERIOD; KIDNEY DISEASE; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL MORTALITY; THROMBOCYTE TRANSFUSION; VASCULAR DISEASE; ADMINISTRATION AND DOSAGE; AGED; PEROPERATIVE CARE; PROCEDURES; TRENDS;

ACUTE KIDNEY INJURY; AGED; CARDIAC SURGICAL PROCEDURES; COLLOIDS; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 85019669830     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2016.12.024     Document Type: Article

References (39)

1. Murray, G.F., Solanke, T., Thompson, et al. Hydroxyethyl starch as a plasma expander in hemorrhagic shock. Surg Forum 16 (1965), 34–35.
2. Perner, A., Haase, N., Guttormsen, A.B., et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. New Engl J Med 367 (2012), 124–134.
3. Myburgh, J.A., Finfer, S., Bellomo, R., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New Engl J Med 367 (2012), 1901–1911.
4. Zarychanski, R., Abou-Setta, A.M., Turgeon, A.F., et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis. JAMA 309 (2013), 678–688.
5. Gillies, M.A., Habicher, M., Jhanji, S., et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: Systemic review and meta-analysis. Br J Anaesth 112 (2014), 25–34.
6. Van Der Linden, P., James, M., Mythen, M., et al. Safety of modern starches used during surgery. Anesth Analg 116 (2013), 35–48.
7. Hand, W.R., Whiteley, J.R., Epperson, T.I., et al. Hydroxyethyl starch and acute kidney injury in orthotopic liver transplantation: A single-center retrospective review. Anesth Analg 120 (2015), 619–626.
8. Ahn, H.J., Kim, J.A., Lee, A.R., et al. The risk of acute kidney injury from fluid restriction and hydroxyethyl starch in thoracic surgery. Anesth Analg 122 (2016), 186–193.
9. Kertai, M.D., Zhou, S., Karhausen, J.A., et al. Platelet counts, acute kidney injury, and mortality after coronary artery bypass grafting surgery. Anesthesiology 124 (2016), 339–352.
10. Kidney Disease. Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2:Suppl (2012), 1–138.
11. Borthwick, E., Ferguson, A., Perioperative acute kidney injury: Risk factors, recognition, management, and outcomes. BMJ, 341, 2010, c3365.
12. Stafford-Smith, M., Shaw, A., Swaminathan, M., Cardiac surgery and acute kidney injury; emerging concepts. Curr Opin Crit Care 15 (2009), 498–502.
13. Kuitunen, A.H., Heikkila, L.J., Salmenpera, M.T., Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation. Ann Thorac Surg 63 (1997), 438–444.
14. Lange, M., Ertmer, C., Van Aken, H., et al. Intravascular volume therapy with colloids in cardiac surgery. J Cardiothorac Vasc Anesth 25 (2011), 845–855.
15. Westphal, M., James, M.F., Kozek-Langenecker, S.A., et al. Hydroxyethyl starches: Different products—different effects. Anesthesiology 111 (2009), 187–202.
16. Boldt, Joachim, Modern rapidly degradable hydroxyethyl starches: Current concepts. Int Anesth Research Society 108 (2009), 1574–1582.
17. Vuiblet, V., Nguyen, T.T., Wynckel, A., et al. Contribution of Raman spectroscopy in nephrology: A candidate technique to detect hydroxyethyl starch of third generation in osmotic renal lesions. Analyst 140 (2015), 7382–7390.
18. Jungheinrich, C., Sauermann, W., Bepperling, F., et al. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: A randomised, double-blind study. Drugs RD 5 (2004), 1–9.
19. Martin, C., Jacob, M., Vicaut, E., et al. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 118 (2013), 387–394.
20. Reilly, C., Retraction. Notice of formal retraction of articles by Dr. Joachim Boldt. Br J Anesth 107 (2011), 116–117.
21. Stevens, L.A., Coresh, J., Greene, T., et al. Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med 354 (2006), 2473–2483.
22. Robert, R.S., Herron, C.R., Groom, R.C., et al. Acute kidney injury subsequent to cardiac surgery. J Extra Corpor Technol 47 (2015), 16–28.
23. Kumar, A.B., Suneja, M., Bayman, E., et al. Association between postoperative acute kidney injury and duration of cardiopulmonary bypass: Meta-analysis. J Cardiothorac Vasc Anesthesia 26 (2012), 64–69.
24. Winkelmayer, W.C., Glynn, R.J., Levin, R., et al. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery. Kidney Int 64 (2003), 1046–1049.
25. Rioux, J.P., Lessard, M., de Bortoli, B., et al. Pentastarch 10% (250kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery. Crit Care Med 31 (2009), 1293–1298.
26. Kozek-Langenecker, S.A., Effects of hydroxyethyl starch solution on hemostasis. Anesthesiology 103 (2005), 654–660.
27. Kuitunen, A.H., Hynynen, M.J., Vahtera, E., et al. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg 98 (2004), 291–297.
28. Niemi, T., Schramko, A., Kuitunen, A., et al. Haemodynamics and acid-base equilibrium after cardiac surgery: Comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Scand J Surg 97 (2008), 259–265.
29. Schramko, A.A., Suojarnanta-Ylinen, R.T., Kuitunen, A.H., et al. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: A prospective randomized trial. Anesth Analg 108 (2009), 30–36.
30. Neff, T.A., Doelberg, M., Jungheinrich, C., et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 96 (2003), 1453–1459.
31. Langeron, O., Doelberg, M., Ang, E.T., et al. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 92 (2001), 855–862.
32. Hecht-Dolnik, M., Barkan, H., Taharka, A., et al. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: A randomized clinical trial. J Thorac Cardiovasc Surg 138 (2009), 703–711.
33. Avorn, J., Patel, M., Levin, R., et al. Hetastarch and bleeding complications after coronary artery surgery. Chest 124 (2003), 1437–1442.
34. Jones, S.B., Whitten, C.W., Despotis, G.J., et al. The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: A preliminary survey of hemostatic markers. Anesth Analg 96 (2003), 363–368.
35. Gandhi, S., Warltier, D., Weiskopf, R., et al. Volume substitution therapy with HES 130/0.4 (Voluven) vs HES 450/0.7 (hetastarch) during major orthopedic surgery (abstract). Crit Care, 9, 2005, P206.
36. Lowell, J., Schifferdecker, C., Driscoll, D., et al. Postoperative fluid overload: Not a benign problem. Crit Care Med 18 (1990), 728–733.
37. Krzych, L., Wybraniec, M., Chudek, J., et al. Perioperative management of cardiac surgery patients who are at the risk of acute kidney injury. Anesth Inten Therapy 45 (2013), 155–163.
38. Bellomo, R., Ronco, C., Kellum, J.A., et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8 (2004), R204–R212.
39. Endre, Z.H., Acute kidney injury: Definitions and new paradigms. Adv Chronic Kidney Dis 15 (2008), 213–221.